• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Viral Vaccines Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 133 Pages
  • Report Code: 24LS-21589
  • Formate :   
Download FREE Report Sample Download PDF File

United States Viral Vaccines -MARKET ADVISORY SERVICES

Viral Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Viral Vaccines market is segmented into
Attenuated Vaccine
Inactivated Vaccine

Segment by Application, the Viral Vaccines market is segmented into
Hospital
Pharmaceutical Factory
Research Institute
Others

Regional and Country-level Analysis
The Viral Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Viral Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Viral Vaccines Market Share Analysis
Viral Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Viral Vaccines business, the date to enter into the Viral Vaccines market, Viral Vaccines product introduction, recent developments, etc.
The major vendors covered:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Market Segments
1.3 Key Viral Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Viral Vaccines Market Size Growth Rate by Type
1.4.2 Attenuated Vaccine
1.4.3 Inactivated Vaccine
1.5 Market by Application
1.5.1 Global Viral Vaccines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmaceutical Factory
1.5.4 Research Institute
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Viral Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Viral Vaccines Revenue 2015-2026
2.1.2 Global Viral Vaccines Sales 2015-2026
2.2 Global Viral Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Viral Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Viral Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Viral Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Viral Vaccines Revenue Forecast by Region (2021-2026)

3 Global Viral Vaccines Competitor Landscape by Players
3.1 Global Top Viral Vaccines Sales by Manufacturers
3.1.1 Global Viral Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Viral Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Viral Vaccines Manufacturers by Revenue
3.2.1 Global Viral Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Viral Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Viral Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2019
3.2.5 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Viral Vaccines Price by Manufacturers
3.4 Global Viral Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Viral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Viral Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Viral Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Viral Vaccines Market Size by Type (2015-2020)
4.1.1 Global Viral Vaccines Sales by Type (2015-2020)
4.1.2 Global Viral Vaccines Revenue by Type (2015-2020)
4.1.3 Viral Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Viral Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Viral Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Viral Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Viral Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Viral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Viral Vaccines Market Size by Application (2015-2020)
5.1.1 Global Viral Vaccines Sales by Application (2015-2020)
5.1.2 Global Viral Vaccines Revenue by Application (2015-2020)
5.1.3 Viral Vaccines Price by Application (2015-2020)
5.2 Viral Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Viral Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Viral Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Viral Vaccines Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Viral Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Viral Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Viral Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Viral Vaccines Market Share in Global Market 2015-2026
6.2 United States Viral Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Viral Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Viral Vaccines Players by Revenue (2015-2020)
6.3 United States Viral Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Viral Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Viral Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Viral Vaccines Price by Type (2015-2020)
6.4 United States Viral Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Viral Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Viral Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Viral Vaccines Price Forecast by Type (2021-2026)
6.5 United States Viral Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Viral Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Viral Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Viral Vaccines Price by Application (2015-2020)
6.6 United States Viral Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Viral Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Viral Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Viral Vaccines Price Forecast by Application (2021-2026)

7 North America
7.1 North America Viral Vaccines Market Size YoY Growth 2015-2026
7.2 North America Viral Vaccines Market Facts & Figures by Country
7.2.1 North America Viral Vaccines Sales by Country (2015-2020)
7.2.2 North America Viral Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Viral Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Viral Vaccines Market Facts & Figures by Country
8.2.1 Europe Viral Vaccines Sales by Country
8.2.2 Europe Viral Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Viral Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Viral Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Viral Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Viral Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Viral Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Viral Vaccines Market Facts & Figures by Country
10.2.1 Latin America Viral Vaccines Sales by Country
10.2.2 Latin America Viral Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Viral Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Viral Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Viral Vaccines Sales by Country
11.2.2 Middle East and Africa Viral Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Viral Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Viral Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Viral Vaccines Products Offered
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Viral Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Viral Vaccines Products Offered
12.5.5 Sanofi Recent Development
12.6 Bayer
12.6.1 Bayer Corporation Information
12.6.2 Bayer Description and Business Overview
12.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bayer Viral Vaccines Products Offered
12.6.5 Bayer Recent Development
12.7 Zoetis
12.7.1 Zoetis Corporation Information
12.7.2 Zoetis Description and Business Overview
12.7.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zoetis Viral Vaccines Products Offered
12.7.5 Zoetis Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Viral Vaccines Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Johnson
12.9.1 Johnson Corporation Information
12.9.2 Johnson Description and Business Overview
12.9.3 Johnson Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Johnson Viral Vaccines Products Offered
12.9.5 Johnson Recent Development
12.10 CSL
12.10.1 CSL Corporation Information
12.10.2 CSL Description and Business Overview
12.10.3 CSL Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSL Viral Vaccines Products Offered
12.10.5 CSL Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GSK Viral Vaccines Products Offered
12.11.5 GSK Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Viral Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Viral Vaccines Market Segments

Table 2. Ranking of Global Top Viral Vaccines Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Viral Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Attenuated Vaccine

Table 5. Major Manufacturers of Inactivated Vaccine

Table 6. Global Viral Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)

Table 7. Global Viral Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 8. Global Viral Vaccines Sales by Regions 2015-2020 (K MT)

Table 9. Global Viral Vaccines Sales Market Share by Regions (2015-2020)

Table 10. Global Viral Vaccines Revenue by Regions 2015-2020 (US$ Million)

Table 11. Global Viral Vaccines Sales Forecast by Region (2021-2026) (K MT)

Table 12. Global Viral Vaccines Sales by Manufacturers (2015-2020) (K MT)

Table 13. Global Viral Vaccines Sales Share by Manufacturers (2015-2020)

Table 14. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2019)

Table 16. Viral Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Viral Vaccines Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Viral Vaccines Price (2015-2020) (USD/MT)

Table 19. Viral Vaccines Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Viral Vaccines Product Type

Table 21. Date of International Manufacturers Enter into Viral Vaccines Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Viral Vaccines Sales by Type (2015-2020) (K MT)

Table 24. Global Viral Vaccines Sales Share by Type (2015-2020)

Table 25. Global Viral Vaccines Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Viral Vaccines Revenue Share by Type (2015-2020)

Table 27. Viral Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 28. Global Viral Vaccines Sales Share by Type (2021-2026)

Table 29. Global Viral Vaccines Sales by Application (2015-2020) (K MT)

Table 30. Global Viral Vaccines Sales Share by Application (2015-2020)

Table 31. Global Viral Vaccines Sales Share by Application (2021-2026)

Table 32. Global Viral Vaccines Sales Market Share Forecast by Application (2021-2026)

Table 33. Global Viral Vaccines Revenue by Application (2015-2020) (US$ Million)

Table 34. Global Viral Vaccines Revenue Market Share Forecast by Application (2021-2026)

Table 35. United States Viral Vaccines Sales (K MT) of Key Companies (2015-2020)

Table 36. United States Viral Vaccines Sales Share by Company (2015-2020)

Table 37. United States Viral Vaccines Revenue (US$ Million) by Company (2015-2020)

Table 38. United States Viral Vaccines Sales (K MT) by Type (2015-2020)

Table 39. United States Viral Vaccines Sales Share by Type (2015-2020)

Table 40. United States Viral Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)

Table 41. United States Viral Vaccines Price (K MT) by Type (2015-2020)

Table 42. United States Viral Vaccines Sales (K MT) by Type (2021-2026)

Table 43. United States Viral Vaccines Sales Share by Type (2021-2026)

Table 44. United States Viral Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)

Table 45. United States Viral Vaccines Revenue Share by Type (2021-2026)

Table 46. United States Viral Vaccines Price (K MT) by Type (2021-2026)

Table 47. United States Viral Vaccines Sales (K MT) by Application (2015-2020)

Table 48. United States Viral Vaccines Sales Share by Application (2015-2020)

Table 49. United States Viral Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)

Table 50. United States Viral Vaccines Sales (K MT) by Application (2021-2026)

Table 51. United States Viral Vaccines Sales Share by Application (2021-2026)

Table 52. United States Viral Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)

Table 53. United States Viral Vaccines Revenue Share by Application (2021-2026)

Table 54. North America Viral Vaccines Sales by Country (2015-2020) (K MT)

Table 55. North America Viral Vaccines Sales Market Share by Country (2015-2020)

Table 56. North America Viral Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 57. North America Viral Vaccines Revenue Market Share by Country (2015-2020)

Table 58. Europe Viral Vaccines Sales by Country (2015-2020) (K MT)

Table 59. Europe Viral Vaccines Sales Market Share by Country (2015-2020)

Table 60. Europe Viral Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 61. Europe Viral Vaccines Revenue Market Share by Country (2015-2020)

Table 62. Asia Pacific Viral Vaccines Sales by Region (2015-2020) (K MT)

Table 63. Asia Pacific Viral Vaccines Sales Market Share by Region (2015-2020)

Table 64. Asia Pacific Viral Vaccines Revenue by Region (2015-2020) (US$ Million)

Table 65. Asia Pacific Viral Vaccines Revenue Market Share by Region (2015-2020)

Table 66. Latin America Viral Vaccines Sales by Country (2015-2020) (K MT)

Table 67. Latin America Viral Vaccines Sales Market Share by Country (2015-2020)

Table 68. Latin Americaa Viral Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 69. Latin America Viral Vaccines Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Viral Vaccines Sales by Country (2015-2020) (K MT)

Table 71. Middle East and Africa Viral Vaccines Sales Market Share by Country (2015-2020)

Table 72. Middle East and Africa Viral Vaccines Revenue by Country (2015-2020) (US$ Million)

Table 73. Middle East and Africa Viral Vaccines Revenue Market Share by Country (2015-2020)

Table 74. GSK Corporation Information

Table 75. GSK Description and Business Overview

Table 76. GSK Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 77. GSK Viral Vaccines Product

Table 78. GSK Recent Development

Table 79. Merck Corporation Information

Table 80. Merck Description and Business Overview

Table 81. Merck Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 82. Merck Product

Table 83. Merck Recent Development

Table 84. Novartis Corporation Information

Table 85. Novartis Description and Business Overview

Table 86. Novartis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 87. Novartis Product

Table 88. Novartis Recent Development

Table 89. Pfizer Corporation Information

Table 90. Pfizer Description and Business Overview

Table 91. Pfizer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 92. Pfizer Product

Table 93. Pfizer Recent Development

Table 94. Sanofi Corporation Information

Table 95. Sanofi Description and Business Overview

Table 96. Sanofi Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 97. Sanofi Product

Table 98. Sanofi Recent Development

Table 99. Bayer Corporation Information

Table 100. Bayer Description and Business Overview

Table 101. Bayer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 102. Bayer Product

Table 103. Bayer Recent Development

Table 104. Zoetis Corporation Information

Table 105. Zoetis Description and Business Overview

Table 106. Zoetis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 107. Zoetis Product

Table 108. Zoetis Recent Development

Table 109. AstraZeneca Corporation Information

Table 110. AstraZeneca Description and Business Overview

Table 111. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 112. AstraZeneca Product

Table 113. AstraZeneca Recent Development

Table 114. Johnson Corporation Information

Table 115. Johnson Description and Business Overview

Table 116. Johnson Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 117. Johnson Product

Table 118. Johnson Recent Development

Table 119. CSL Corporation Information

Table 120. CSL Description and Business Overview

Table 121. CSL Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 122. CSL Product

Table 123. CSL Recent Development

Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 125. Key Challenges

Table 126. Market Risks

Table 127. Main Points Interviewed from Key Viral Vaccines Players

Table 128. Viral Vaccines Customers List

Table 129. Viral Vaccines Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Viral Vaccines Product Picture

Figure 2. Global Viral Vaccines Sales Market Share by Type in 2020 & 2026

Figure 3. Attenuated Vaccine Product Picture

Figure 4. Inactivated Vaccine Product Picture

Figure 5. Global Viral Vaccines Sales Market Share by Application in 2020 & 2026

Figure 6. Hospital

Figure 7. Pharmaceutical Factory

Figure 8. Research Institute

Figure 9. Others

Figure 10. Viral Vaccines Report Years Considered

Figure 11. Global Viral Vaccines Market Size 2015-2026 (US$ Million)

Figure 12. Global Viral Vaccines Sales 2015-2026 (K MT)

Figure 13. Global Viral Vaccines Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Viral Vaccines Sales Market Share by Region (2015-2020)

Figure 15. Global Viral Vaccines Sales Market Share by Region in 2019

Figure 16. Global Viral Vaccines Revenue Market Share by Region (2015-2020)

Figure 17. Global Viral Vaccines Revenue Market Share by Region in 2019

Figure 18. Global Viral Vaccines Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Viral Vaccines Revenue in 2019

Figure 20. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Viral Vaccines Sales Market Share by Type (2015-2020)

Figure 22. Global Viral Vaccines Sales Market Share by Type in 2019

Figure 23. Global Viral Vaccines Revenue Market Share by Type (2015-2020)

Figure 24. Global Viral Vaccines Revenue Market Share by Type in 2019

Figure 25. Global Viral Vaccines Market Share by Price Range (2015-2020)

Figure 26. Global Viral Vaccines Sales Market Share by Application (2015-2020)

Figure 27. Global Viral Vaccines Sales Market Share by Application in 2019

Figure 28. Global Viral Vaccines Revenue Market Share by Application (2015-2020)

Figure 29. Global Viral Vaccines Revenue Market Share by Application in 2019

Figure 30. United States Viral Vaccines Sales Growth Rate 2015-2026 (K MT)

Figure 31. United States Viral Vaccines Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. United States Viral Vaccines Market Share in Global Market 2015-2026

Figure 33. United States 5 and 10 Largest Viral Vaccines Players Market Share by Revenue in Viral Vaccines in 2019

Figure 34. United States Viral Vaccines Revenue Share by Type (2015-2020)

Figure 35. United States Viral Vaccines Revenue Growth Rate by Type in 2015 & 2019

Figure 36. United States Viral Vaccines Revenue Share by Application (2015-2020)

Figure 37. United States Viral Vaccines Revenue Growth Rate by Application in 2015 & 2019

Figure 38. North America Viral Vaccines Sales Growth Rate 2015-2020 (K MT)

Figure 39. North America Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. North America Viral Vaccines Sales Market Share by Country in 2019

Figure 41. North America Viral Vaccines Revenue Market Share by Country in 2019

Figure 42. U.S. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 43. U.S. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Canada Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 45. Canada Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Europe Viral Vaccines Sales Growth Rate 2015-2020 (K MT)

Figure 47. Europe Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Viral Vaccines Sales Market Share by Country in 2019

Figure 49. Europe Viral Vaccines Revenue Market Share by Country in 2019

Figure 50. Germany Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 51. Germany Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 53. France Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 55. U.K. Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 57. Italy Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 59. Russia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Asia Pacific Viral Vaccines Sales Growth Rate 2015-2020 (K MT)

Figure 61. Asia Pacific Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Viral Vaccines Sales Market Share by Region in 2019

Figure 63. Asia Pacific Viral Vaccines Revenue Market Share by Region in 2019

Figure 64. China Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 65. China Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 67. Japan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 69. South Korea Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 71. India Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 73. Australia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 75. Taiwan Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 77. Indonesia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 79. Thailand Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 81. Malaysia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 83. Philippines Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 85. Vietnam Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Latin America Viral Vaccines Sales Growth Rate 2015-2020 (K MT)

Figure 87. Latin America Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Viral Vaccines Sales Market Share by Country in 2019

Figure 89. Latin America Viral Vaccines Revenue Market Share by Country in 2019

Figure 90. Mexico Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 91. Mexico Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 93. Brazil Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 95. Argentina Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Middle East and Africa Viral Vaccines Sales Growth Rate 2015-2020 (K MT)

Figure 97. Middle East and Africa Viral Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Viral Vaccines Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Viral Vaccines Revenue Market Share by Country in 2019

Figure 100. Turkey Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 101. Turkey Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 103. Saudi Arabia Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Viral Vaccines Sales Growth Rate (2015-2020) (K MT)

Figure 105. U.A.E Viral Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Porter's Five Forces Analysis

Figure 107. Viral Vaccines Value Chain

Figure 108. Channels of Distribution

Figure 109. Distributors Profiles

Figure 110. Bottom-up and Top-down Approaches for This Report

Figure 111. Data Triangulation

Figure 112. Key Executives Interviewed

GSK

Merck

Novartis

Pfizer

Sanofi

Bayer

Zoetis

AstraZeneca

Johnson

CSL

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase